Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
186 participants
INTERVENTIONAL
2010-10-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to assess the effects of inclusion of whole grain in the diet on anthropometric measures, particularly abdominal fat regain after a weight loss diet.
It is anticipated that the short-term regain of abdominal fat after a weight loss diet is lower in volunteers consuming whole grain than in volunteers consuming refined grain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Grains Reduce Adiposity and Improve Nutrition Study
NCT00924521
Effects of a Wholegrain Diet on Body Composition and Energy Balance
NCT01411540
Effect of Wholegrain Wheat on Body Weight and Composition and Cardiovascular Risk
NCT00869531
Whole Grains, Gastric Emptying and Glycemic Response
NCT03467659
Health Effects of Grain Foods in Adults
NCT06339879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whole grain diet
Diet rich in whole grain
Ready-to-eat breakfast cereals and other cereal products, rich in whole grain
Refined grain diet
Refined grain
Ready-to-eat breakfast cereals and other cereal products, low in whole grain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet rich in whole grain
Ready-to-eat breakfast cereals and other cereal products, rich in whole grain
Refined grain
Ready-to-eat breakfast cereals and other cereal products, low in whole grain
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-menopausal woman,
* BMI between 27 and 34 kg/m²
* Waist circumference \> 80 cm.
* No diet within the last 3 months with weight loss or gain not more than 3kg.
* Non-smoking subject, or smoking less than 15 cigarettes/day since three months,
* Normal blood pressure (BP) and heart rate (HR) after 10 minutes in supine position. Individuals values out of the normal range can be accepted if judged clinically non relevant by the investigator.
* Laboratory parameters within the normal range of the laboratory (haematological, blood chemistry tests, urinalysis). Individual values out of the normal range can be accepted if judged clinically non relevant by the Investigator.
* Subject with a habitual low (\< 16 g/day) intake of whole grain foods (from cereal food intake questionnaire),
* willing to eat breakfast cereals
* no intense physical activity,
* written consent to participate in the study,
* covered by Health Insurance System and / or in compliance with the recommendations of National Law in force relating to biomedical research.
* registered in the national file of volunteers participating in biomedical research,
* Subject who has lost at least 6% initial body weight after the weight loss diet will be randomized to either the whole grain or the refined grain diet
Exclusion Criteria
* Subject suffering from chronic renal insufficiency
* Subject receiving a local or general treatment (i.e, prescription medications, over-the-counter medications, dietary supplements or herbal supplements) susceptible to interfere with the evaluation of the studied parameters and in particular weight (eg, appetite suppressants, slimming or treatment which could interfere with the metabolism and dietary behaviour),
* Subject with ongoing medication not stabilized since more than 3 months,
* Subject having had a general anaesthesia in the month preceding inclusion, or gastro-intestinal surgery at any time in his/her life, with the possible exception of appendectomy,
* Pregnant or breast-feeding subject (positive urinary pregnancy test),
* Subject in an exclusion period of a previous study or having participated in another clinical study in the last month,
* Use of laxatives, except in few occasions, if, in the opinion of the investigator, does not interfere with the optimal participation,
* Subject having received more than 4500 Euros in indemnity for participation in clinical studies in the last 12 months, including participation in the present study,
* Subject in a situation that, in the opinion of the investigator, could interfere with his optimal participation in the study or constitute a particular risk for the subject,
* Subject under any administrative or legal supervision.
* Subjects with known allergies to cereals
20 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cereal Partners Worldwide
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yves DONAZZOLO, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Optimed Clinical Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Optimed Clinical Research
Gières, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009.02.CPW / OP71709.UPC.CPW
Identifier Type: -
Identifier Source: org_study_id
NCT01848405
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.